We all know that cholesterol is bad. We all know that high blood pressure is bad. We all know we should watch our diet and exercise. But where, exactly, did those insights come from? They largely came from the Framingham Heart Study, which followed approximately 5000 people from the small town of Framingham in Massachusetts, USA, for decades to evaluate their risk of cardiovascular disease. Extensive questionnaires and regular physical exams, later expanded to include ECG, echocardiography and X-rays, were analyzed to identify risk factors for sudden death, angina pectoris, myocardial infarction and stroke. Begun in 1948, the study later included the Offspring Study, and in 2002 the Third Generation study was begun.
I found it fascinating to dig a little deeper into the origin of this epidemiological survey, which every medical student hears about. It had humble beginnings in the post-WWII years, when steak, mashed potatoes and gravy were considered a hearty, nutritious meal and most men smoked, courtesy of the cigarettes that had been provided as part of their rations during WWII - but also a time when the idea of serving the greater good was appealing and natural to most folks. A serious effort to reassure the local doctors that the Heart Study would just evaluate, not treat or "steal" their patients was absolutely necessary, as was the work of grassroots volunteers who would walk around Framingham convincing individuals to sign up.
From the technical point of view, the data from the Heart Study was kept on punch cards for decades, until the 1980s. And according to the author, the statistical technique called multivariate analysis was developed at the National Institutes of Health specifically to help untangle the multiple variables of cardiovascular health that the Study uncovered. In the course of its lifetime (or at least until 2005, when this book was written), the Study survived two major threats to its existence. The first was an effort in 1968 to shut it down, partially because certain influential cardiologists felt that over the 20 years of its existence, the study had yielded all the data it was ever going to produce, and partially because funding was being driven into the War on Cancer. And around 2000, Boston University came up with an ill-conceived plan to form a for-profit company to use and sell the study data. As expected, the participants rose up in arms against this violation of the original premise (and promise) of the Study, and the project was shut down.
Some of the most interesting chapters were about how the insights about cholesterol, hypertension and smoking came about. The Framingham Study certainly played an important role, as did epidemiological studies of countries where cardiovascular disease was infrequent, in determining what foods to select and avoid. The chapter on homocysteine as risk factor for cardiovascular disease was informative as well.
Overall, an interesting book that allows a peek behind the curtain of the study whose recommendations now widely known (if not always implemented, specifically the warnings about sedentarism and obesity).